Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04229979
Title GPS Compared With BAT in AML CR2/CR2p
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Sellas Life Sciences Group
Indications

acute myeloid leukemia

Therapies

Galinpepimut-S

Cytarabine

Decitabine

Venetoclax

Azacitidine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.